Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04320537 · ClinicalTrials.gov registry record
Brain Neurochemical Profile During Marijuana Abstinence
A clinical trial, sponsored by Mclean Hospital.
- Completed
- Registry status
- 37
- Enrollment target
NCT04320537: Completed study, sponsored by Mclean Hospital.
NCT04320537 is a clinical trial that has completed, run by Mclean Hospital. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04320537 has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
We have interviewed more than 120+ candidates and recruited 44 chronic marijuana users and 11 non-user healthy controls: 26 of the 44 MJ users actually participated in the study, 6 of the 26 MJ participants dropped out after their baseline magnetic resonance (MR) visits and the remaining 20 participants completed the study protocol, namely completed three MR visits for measurement of brain metabolites (baseline, day 7, and day 21); among the 11 healthy controls, 10 completed the study protocol. We are currently analyzing collected data and preparing manuscripts for peer reviewed journals.
Primary Outcome
brain metabolites correlated with withdrawal symptoms
Interventions
- OTHER abstinence from use of marijuana and other abused drugs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2020-01-31 |
What the finished NCT04320537 record still lists
NCT04320537 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which abstinence from use of marijuana and other abused drugs is the first listed.
NCT04320537 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04320537 about?
NCT04320537 is a clinical study titled "Brain Neurochemical Profile During Marijuana Abstinence". We have interviewed more than 120+ candidates and recruited 44 chronic marijuana users and 11 non-user healthy controls: 26 of the 44 MJ users actually participated in the study, 6 of the 26 MJ participants dropped out after their baseline magnetic resonance (MR) visits and the remaining 20 particip...
What is the current status of trial NCT04320537?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2017-07-01. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT04320537?
The interventions under investigation include: abstinence from use of marijuana and other abused drugs (OTHER).
Who is sponsoring clinical trial NCT04320537?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI